Skip to content

Clinical cohort study of low-energy shockwave therapy for male erectile dysfunction

Clinical cohort study of low-energy shockwave therapy for male erectile dysfunction - Low-energy shockwave therapy for erectile dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064274
Enrollment
Unknown
Registered
2022-10-01
Start date
2022-10-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile dysfunction

Interventions

Low energy shock wave treatment group:Low energy shock wave therapy

Sponsors

Shenzhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
22 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Voluntarily enrolled in the study and signed an informed consent form. 2. Married men aged 22-65 years with a regular sexual partner and a regular sexual life. 3. Have a previous clinical diagnosis of erectile dysfunction and are effectively treated with oral 5 phosphodiesterase inhibitor medication as prescribed by a physician. 4. No use of treatment related to erectile dysfunction (psychotherapy and 5 phosphodiesterase inhibitor medication) within the last two weeks. 5. Agree not to use other treatment options related to erectile dysfunction, such as surgical

Exclusion criteria

Exclusion criteria: 1. Patients with functional erectile dysfunction. 2. Patients with erectile dysfunction confirmed by the investigator to be ineffective on oral 5 phosphodiesterase inhibitor therapy based on the patient's medical history and ancillary tests. 3. Patients with a history of severe pelvic surgery, such as bladder cancer, prostate cancer treated surgically, radiotherapy, endocrine or chemotherapy for erectile dysfunction. 4. Patients with unstable psychosomatic disorders, patients with cerebrospinal injury, pelvic fracture, urethral injury surgically treated for erectile dysfunction 5. Patients with penile deformity, severe penile sclerosis combined with curved erectile dysfunction 6. Patients with blood routine suggestive of acute and chronic hematologic disorders and acute and chronic infections erectile dysfunction. 7. Patients with urine routine suggestive of acute and chronic urinary tract infections and untreated erectile dysfunction. 8. Patients judged by the investigator to be unsuitable for participation in this clinical trial.

Design outcomes

Primary

MeasureTime frame
IIEF-EF;Penile ultrasound blood flow improvement rate;Clinical efficacy evaluation;

Secondary

MeasureTime frame
EHS;SEP;GAQ;

Countries

China

Contacts

Public ContactBentao Shi

Shenzhen Second People's Hospital

shibentaopku@126.com+86 13688802408

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026